Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_1
1
13%
Ph phase_3
2
25%
Ph not_applicable
2
25%
Ph phase_2
3
38%

Phase Distribution

1

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
2(25.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Terminated(2)
Other(1)

Detailed Status

Completed5
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
71.4%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 23 (37.5%)
Phase 32 (25.0%)
N/A2 (25.0%)

Trials by Status

unknown113%
completed563%
terminated225%

Recent Activity

0 active trials
Showing 5 of 8
terminatedphase_2

Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants

NCT02620761
terminatednot_applicable

The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery

NCT00743106
completedphase_3

Fenoldopam and Acute Renal Failure

NCT00621790
completedphase_2

An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery

NCT00122018
unknownphase_1

Effect of Gene Variants on Dopamine Receptor Natriuretic Responses

NCT00592150
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02620761Phase 2

Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants

Terminated
NCT00743106Not Applicable

The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery

Terminated
NCT00621790Phase 3

Fenoldopam and Acute Renal Failure

Completed
NCT00122018Phase 2

An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery

Completed
NCT00592150Phase 1

Effect of Gene Variants on Dopamine Receptor Natriuretic Responses

Unknown
NCT00982527Phase 3

Fenoldopam in Pediatric Cardiac Surgery

Completed
NCT01324245Not Applicable

Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

Completed
NCT00467181Phase 2

A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8